- Home
- ARBE vs ENTA Comparison
ARBE vs ENTA Comparison
Compare ARBE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- ENTA
- Stock Information
- Founded
- ARBE 2015
- ENTA 1995
- Country
- ARBE Israel
- ENTA United States
- Employees
- ARBE N/A
- ENTA N/A
- Industry
- ARBE EDP Services
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- ARBE Technology
- ENTA Health Care
- Exchange
- ARBE Nasdaq
- ENTA Nasdaq
- Market Cap
- ARBE 203.2M
- ENTA 164.6M
- IPO Year
- ARBE N/A
- ENTA 2013
- Fundamental
- Price
- ARBE $1.30
- ENTA $8.40
- Analyst Decision
- ARBE Buy
- ENTA Strong Buy
- Analyst Count
- ARBE 2
- ENTA 4
- Target Price
- ARBE $1.75
- ENTA $20.75
- AVG Volume (30 Days)
- ARBE 1.1M
- ENTA 143.1K
- Earning Date
- ARBE 08-07-2025
- ENTA 08-11-2025
- Dividend Yield
- ARBE N/A
- ENTA N/A
- EPS Growth
- ARBE N/A
- ENTA N/A
- EPS
- ARBE N/A
- ENTA N/A
- Revenue
- ARBE $536,000.00
- ENTA $64,806,000.00
- Revenue This Year
- ARBE $301.82
- ENTA N/A
- Revenue Next Year
- ARBE $250.52
- ENTA $1.65
- P/E Ratio
- ARBE N/A
- ENTA N/A
- Revenue Growth
- ARBE N/A
- ENTA N/A
- 52 Week Low
- ARBE $0.85
- ENTA $4.09
- 52 Week High
- ARBE $5.09
- ENTA $13.43
- Technical
- Relative Strength Index (RSI)
- ARBE 44.06
- ENTA 56.86
- Support Level
- ARBE $1.16
- ENTA $8.47
- Resistance Level
- ARBE $1.46
- ENTA $9.09
- Average True Range (ATR)
- ARBE 0.07
- ENTA 0.52
- MACD
- ARBE 0.02
- ENTA 0.05
- Stochastic Oscillator
- ARBE 47.54
- ENTA 72.94
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.